COVID-19 virus enters the cell via the angiotensin-converting enzyme-2 (ACE-2) receptor, and the ACE-2 expression was found to be drastically elevated in COPD patients, but also among smokers and frequent nicotine users [6-8]. This evidence concerns the gene ACE2 and COVID-19.